Efficacy of Topical Treatment of Low-Risk Cervical Preinvasive Lesions with Glycyrrhizinic Acid

被引:0
作者
Andzane, Diana [1 ,2 ,3 ,4 ]
Zodzika, Jana [1 ,2 ]
Jermakova, Irina [1 ]
Senfelde, Ilva [1 ]
Utorova, Marina [1 ]
Rezeberga, Dace [1 ,2 ,3 ]
机构
[1] Riga East Clin Univ Hosp, Gynaecol Clin, Hipokrata St 2, LV-1079 Riga, Latvia
[2] Riga Stradins Univ, Dept Obstet & Gynaecol, Miera St 45, LV-1013 Riga, Latvia
[3] Riga Matern Hosp, Miera St 45, LV-1013 Riga, Latvia
[4] Riga Stradins Univ, Dept Clin Skills & Med Technol, Anninmuizas Bulvaris 26A, LV-1067 Riga, Latvia
关键词
cervical intraepithelial neoplasia; human papillomavirus; glycyrrhizinic acid; colposcopy; cervical precancerous disease; INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS; INFECTION; WOMEN;
D O I
10.3390/jcm14010136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: The study aimed to investigate the efficacy of medication treatment with glycyrrhizinic acid for cervical intraepithelial neoplasia (CIN) 1 lesions. Methods: Women with histologically confirmed CIN 1 in cervical biopsies were included in the prospective study. Participants of the study group used glycyrrhizinic acid spray (Epigen spray) topically 10 days (Epigen 10-day subgroup) or 20 days (Epigen 20-day subgroup) per month for 6 months. Women in the control group had no treatment. There were two follow-up visits 6 months apart. All patients were screened for human papillomavirus (HPV) before enrollment and during the first follow-up visit. Results: There were 50 patients in the Epigen group and 50 patients in the control group. At the first follow-up visit, in the histological findings, progression to CIN 2+ was 6.7% in the Epigen 20-day subgroup, 31.1% in the control group, and the persistence of CIN 1 was 86.7% in the Epigen 20-day subgroup and 62.2% in the control group, p = 0.03. Large loop excision of the transformation zone (LLETZ) was statistically significantly more frequent in the control group after the first follow-up visit (10% in the Epigen 20-day subgroup vs. 30% in the control group, p = 0.032). No such relationships were found during the second follow-up visit. Conclusions: The vaginal spray of the glycyrrhizinic acid used 20 days per month appears to decrease the risk of the progression of CIN 1 lesions, with the need to perform LLETZ. However, a similar effect is not observed after stopping usage.
引用
收藏
页数:13
相关论文
共 24 条
[1]  
Bisht Dheeraj, 2022, Phytomed Plus, V2, P100206, DOI 10.1016/j.phyplu.2021.100206
[2]   Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings [J].
Bruni, Laia ;
Diaz, Mireia ;
Castellsague, Xavier ;
Ferrer, Elena ;
Bosch, F. Xavier ;
de Sanjose, Silvia .
JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (12) :1789-1799
[3]   Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study [J].
Ciavattini, Andrea ;
Serri, Matteo ;
Di Giuseppe, Jacopo ;
Liverani, Carlo Antonio ;
Gardella, Barbara ;
Papiccio, Maria ;
Delli Carpini, Giovanni ;
Morini, Stefano ;
Clemente, Nicolo ;
Sopracordevole, Francesco .
BMJ OPEN, 2019, 9 (07)
[4]   Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2-3: A narrative review [J].
Desravines, Nerlyne ;
Miele, Kate ;
Carlson, Rebecca ;
Chibwesha, Carla ;
Rahangdale, Lisa .
GYNECOLOGIC ONCOLOGY REPORTS, 2020, 33
[5]   Significance and possible causes of false-negative results of reflex human papillomavirus infection testing [J].
Eltoum, Isam A. ;
Chhieng, David C. ;
Crowe, D. Ralph ;
Roberson, Janie ;
Jin, Ge ;
Broker, Thomas R. .
CANCER CYTOPATHOLOGY, 2007, 111 (03) :154-159
[6]  
European Federation for Colposcopy Performance Standards, About us
[7]   Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer [J].
Gonzalez-Bosquet, Eduardo ;
Fernandez, Sergi ;
Sabra, Sally ;
Lailla, Jose M. .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 136 (02) :229-231
[8]  
Graebin CS, 2018, REF SER PHYTOCHEM, P245, DOI 10.1007/978-3-319-27027-2_15
[9]   Innovative Diagnostic and Therapeutic Interventions in Cervical Dysplasia: A Systematic Review of Controlled Trials [J].
Hecken, Julia M. ;
Rezniczek, Guenther A. ;
Tempfer, Clemens B. .
CANCERS, 2022, 14 (11)
[10]   Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study [J].
Hendriks, Natasja ;
Koeneman, Margot M. ;
van de Sande, Anna J. M. ;
Penders, Charlotte G. J. ;
Piek, Jurgen M. J. ;
Kooreman, Loes F. S. ;
van Kuijk, Sander M. J. ;
Hoosemans, Linde ;
Sep, Simone J. S. ;
de Vos Van Steenwijk, Peggy J. ;
van Beekhuizen, Heleen J. ;
Slangen, Brigitte F. M. ;
Nijman, Hans W. ;
Kruitwagen, Roy F. P. M. ;
Kruse, Arnold-Jan .
JOURNAL OF IMMUNOTHERAPY, 2022, 45 (03) :180-186